nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—ALAS2—hematopoietic system—hematologic cancer	0.0074	0.0282	CbGeAlD
Glycine—GPR18—hematopoietic system—hematologic cancer	0.00684	0.0261	CbGeAlD
Glycine—GLYATL1—lung—hematologic cancer	0.00603	0.023	CbGeAlD
Glycine—GLYATL2—blood—hematologic cancer	0.00585	0.0223	CbGeAlD
Glycine—GLYATL2—bone marrow—hematologic cancer	0.00566	0.0216	CbGeAlD
Glycine—GLDC—hematopoietic system—hematologic cancer	0.00531	0.0203	CbGeAlD
Glycine—GPR18—gonad—hematologic cancer	0.0052	0.0199	CbGeAlD
Glycine—ALAS2—blood—hematologic cancer	0.0049	0.0187	CbGeAlD
Glycine—ALAS2—bone marrow—hematologic cancer	0.00474	0.0181	CbGeAlD
Glycine—GRIN3B—lung—hematologic cancer	0.00457	0.0175	CbGeAlD
Glycine—GPR18—blood—hematologic cancer	0.00453	0.0173	CbGeAlD
Glycine—SLC32A1—testis—hematologic cancer	0.00446	0.017	CbGeAlD
Glycine—GPR18—bone marrow—hematologic cancer	0.00439	0.0168	CbGeAlD
Glycine—AGXT2—gonad—hematologic cancer	0.00432	0.0165	CbGeAlD
Glycine—SLC6A9—testis—hematologic cancer	0.00431	0.0165	CbGeAlD
Glycine—GRIN3B—testis—hematologic cancer	0.00431	0.0165	CbGeAlD
Glycine—ALAS2—lung—hematologic cancer	0.0043	0.0164	CbGeAlD
Glycine—ALAS1—hematopoietic system—hematologic cancer	0.00422	0.0161	CbGeAlD
Glycine—L-Cysteine—MGMT—hematologic cancer	0.0041	1	CrCbGaD
Glycine—ALAS2—testis—hematologic cancer	0.00405	0.0155	CbGeAlD
Glycine—GPR18—lung—hematologic cancer	0.00397	0.0152	CbGeAlD
Glycine—GARS—hematopoietic system—hematologic cancer	0.00384	0.0147	CbGeAlD
Glycine—GPR18—testis—hematologic cancer	0.00375	0.0143	CbGeAlD
Glycine—GCSH—lung—hematologic cancer	0.00372	0.0142	CbGeAlD
Glycine—GNMT—blood—hematologic cancer	0.00371	0.0142	CbGeAlD
Glycine—GATM—hematopoietic system—hematologic cancer	0.00365	0.0139	CbGeAlD
Glycine—GLDC—blood—hematologic cancer	0.00352	0.0134	CbGeAlD
Glycine—GCSH—testis—hematologic cancer	0.00351	0.0134	CbGeAlD
Glycine—SHMT2—hematopoietic system—hematologic cancer	0.00334	0.0128	CbGeAlD
Glycine—PIPOX—blood—hematologic cancer	0.00329	0.0126	CbGeAlD
Glycine—GCAT—blood—hematologic cancer	0.00319	0.0122	CbGeAlD
Glycine—SLC6A9—lymph node—hematologic cancer	0.00312	0.0119	CbGeAlD
Glycine—AGXT2—testis—hematologic cancer	0.00312	0.0119	CbGeAlD
Glycine—GLDC—lung—hematologic cancer	0.00309	0.0118	CbGeAlD
Glycine—GCAT—bone marrow—hematologic cancer	0.00308	0.0118	CbGeAlD
Glycine—SHMT1—hematopoietic system—hematologic cancer	0.00304	0.0116	CbGeAlD
Glycine—GARS—gonad—hematologic cancer	0.00292	0.0112	CbGeAlD
Glycine—GLDC—testis—hematologic cancer	0.00291	0.0111	CbGeAlD
Glycine—PIPOX—lung—hematologic cancer	0.00288	0.011	CbGeAlD
Glycine—GCAT—lung—hematologic cancer	0.00279	0.0107	CbGeAlD
Glycine—ALAS1—blood—hematologic cancer	0.00279	0.0107	CbGeAlD
Glycine—GATM—gonad—hematologic cancer	0.00277	0.0106	CbGeAlD
Glycine—PIPOX—testis—hematologic cancer	0.00272	0.0104	CbGeAlD
Glycine—GPR18—lymph node—hematologic cancer	0.00272	0.0104	CbGeAlD
Glycine—ALAS1—bone marrow—hematologic cancer	0.0027	0.0103	CbGeAlD
Glycine—GCAT—testis—hematologic cancer	0.00264	0.0101	CbGeAlD
Glycine—GCSH—lymph node—hematologic cancer	0.00255	0.00973	CbGeAlD
Glycine—GARS—blood—hematologic cancer	0.00255	0.00972	CbGeAlD
Glycine—SHMT2—gonad—hematologic cancer	0.00254	0.00971	CbGeAlD
Glycine—GARS—bone marrow—hematologic cancer	0.00246	0.00941	CbGeAlD
Glycine—ALAS1—lung—hematologic cancer	0.00245	0.00936	CbGeAlD
Glycine—SHMT1—gonad—hematologic cancer	0.00231	0.00884	CbGeAlD
Glycine—ALAS1—testis—hematologic cancer	0.00231	0.00883	CbGeAlD
Glycine—GSS—hematopoietic system—hematologic cancer	0.00228	0.00873	CbGeAlD
Glycine—GARS—lung—hematologic cancer	0.00223	0.00852	CbGeAlD
Glycine—SHMT2—blood—hematologic cancer	0.00221	0.00846	CbGeAlD
Glycine—SHMT2—bone marrow—hematologic cancer	0.00214	0.00818	CbGeAlD
Glycine—GATM—lung—hematologic cancer	0.00212	0.00809	CbGeAlD
Glycine—GLDC—lymph node—hematologic cancer	0.00211	0.00806	CbGeAlD
Glycine—GARS—testis—hematologic cancer	0.00211	0.00804	CbGeAlD
Glycine—GRIN2C—testis—hematologic cancer	0.00207	0.00791	CbGeAlD
Glycine—SHMT1—Podofilox—Teniposide—hematologic cancer	0.00204	0.221	CbGdCrCtD
Glycine—SHMT1—blood—hematologic cancer	0.00202	0.0077	CbGeAlD
Glycine—GATM—testis—hematologic cancer	0.002	0.00763	CbGeAlD
Glycine—SLC36A1—gonad—hematologic cancer	0.00197	0.00754	CbGeAlD
Glycine—SHMT1—bone marrow—hematologic cancer	0.00195	0.00745	CbGeAlD
Glycine—SHMT2—lung—hematologic cancer	0.00194	0.00741	CbGeAlD
Glycine—GCAT—lymph node—hematologic cancer	0.00191	0.0073	CbGeAlD
Glycine—SHMT2—testis—hematologic cancer	0.00183	0.007	CbGeAlD
Glycine—GLRB—lung—hematologic cancer	0.00182	0.00695	CbGeAlD
Glycine—SHMT1—lung—hematologic cancer	0.00177	0.00675	CbGeAlD
Glycine—GSS—gonad—hematologic cancer	0.00174	0.00663	CbGeAlD
Glycine—ALAS1—lymph node—hematologic cancer	0.00168	0.0064	CbGeAlD
Glycine—SLC16A10—hematopoietic system—hematologic cancer	0.00167	0.00639	CbGeAlD
Glycine—SHMT1—testis—hematologic cancer	0.00167	0.00637	CbGeAlD
Glycine—SLC36A1—bone marrow—hematologic cancer	0.00166	0.00635	CbGeAlD
Glycine—GARS—lymph node—hematologic cancer	0.00153	0.00583	CbGeAlD
Glycine—GSS—blood—hematologic cancer	0.00151	0.00578	CbGeAlD
Glycine—SLC36A1—lung—hematologic cancer	0.00151	0.00576	CbGeAlD
Glycine—GSS—bone marrow—hematologic cancer	0.00146	0.00559	CbGeAlD
Glycine—GATM—lymph node—hematologic cancer	0.00145	0.00553	CbGeAlD
Glycine—GRIN2A—testis—hematologic cancer	0.00143	0.00547	CbGeAlD
Glycine—SLC36A1—testis—hematologic cancer	0.00142	0.00543	CbGeAlD
Glycine—SHMT2—lymph node—hematologic cancer	0.00133	0.00507	CbGeAlD
Glycine—GSS—lung—hematologic cancer	0.00133	0.00507	CbGeAlD
Glycine—SHMT1—Vincristine—Vinorelbine—hematologic cancer	0.0013	0.141	CbGdCrCtD
Glycine—SLC16A10—gonad—hematologic cancer	0.00127	0.00486	CbGeAlD
Glycine—GSS—testis—hematologic cancer	0.00125	0.00478	CbGeAlD
Glycine—GLRB—lymph node—hematologic cancer	0.00124	0.00475	CbGeAlD
Glycine—SHMT1—Podofilox—Etoposide—hematologic cancer	0.00121	0.132	CbGdCrCtD
Glycine—SHMT1—lymph node—hematologic cancer	0.00121	0.00462	CbGeAlD
Glycine—SLC16A10—blood—hematologic cancer	0.00111	0.00423	CbGeAlD
Glycine—SHMT1—Vinblastine—Vinorelbine—hematologic cancer	0.00104	0.113	CbGdCrCtD
Glycine—SHMT1—Vincristine—Vinblastine—hematologic cancer	0.00104	0.113	CbGdCrCtD
Glycine—SLC36A1—lymph node—hematologic cancer	0.00103	0.00394	CbGeAlD
Glycine—SLC16A10—lung—hematologic cancer	0.000972	0.00371	CbGeAlD
Glycine—SLC16A10—testis—hematologic cancer	0.000917	0.0035	CbGeAlD
Glycine—GSS—lymph node—hematologic cancer	0.000907	0.00347	CbGeAlD
Glycine—SHMT1—Vinblastine—Vincristine—hematologic cancer	0.000834	0.0906	CbGdCrCtD
Glycine—SLC16A10—lymph node—hematologic cancer	0.000665	0.00254	CbGeAlD
Glycine—Pain—Vinorelbine—hematologic cancer	0.000295	0.000827	CcSEcCtD
Glycine—Dizziness—Nilotinib—hematologic cancer	0.000293	0.000821	CcSEcCtD
Glycine—Oedema—Vincristine—hematologic cancer	0.000292	0.000819	CcSEcCtD
Glycine—Dizziness—Imatinib—hematologic cancer	0.000291	0.000816	CcSEcCtD
Glycine—Hypersensitivity—Melphalan—hematologic cancer	0.000291	0.000815	CcSEcCtD
Glycine—Nausea—Procarbazine—hematologic cancer	0.00029	0.000814	CcSEcCtD
Glycine—Thrombophlebitis—Doxorubicin—hematologic cancer	0.000288	0.000808	CcSEcCtD
Glycine—Vomiting—Chlorambucil—hematologic cancer	0.000288	0.000807	CcSEcCtD
Glycine—Dizziness—Cladribine—hematologic cancer	0.000286	0.000802	CcSEcCtD
Glycine—Hypotension—Carmustine—hematologic cancer	0.000286	0.000801	CcSEcCtD
Glycine—Nausea—Bexarotene—hematologic cancer	0.000285	0.000798	CcSEcCtD
Glycine—Nausea—Dasatinib—hematologic cancer	0.000285	0.000798	CcSEcCtD
Glycine—Oedema—Irinotecan—hematologic cancer	0.000284	0.000797	CcSEcCtD
Glycine—Oedema—Mitoxantrone—hematologic cancer	0.000284	0.000797	CcSEcCtD
Glycine—Nausea—Fludarabine—hematologic cancer	0.000284	0.000796	CcSEcCtD
Glycine—Diarrhoea—Vinblastine—hematologic cancer	0.000284	0.000796	CcSEcCtD
Glycine—Hypotension—Alitretinoin—hematologic cancer	0.000283	0.000794	CcSEcCtD
Glycine—Hypersensitivity—Lenalidomide—hematologic cancer	0.000283	0.000793	CcSEcCtD
Glycine—Pain—Thiotepa—hematologic cancer	0.000281	0.000789	CcSEcCtD
Glycine—Vomiting—Nilotinib—hematologic cancer	0.000281	0.000789	CcSEcCtD
Glycine—Urticaria—Bortezomib—hematologic cancer	0.00028	0.000786	CcSEcCtD
Glycine—Back pain—Etoposide—hematologic cancer	0.00028	0.000786	CcSEcCtD
Glycine—Vomiting—Imatinib—hematologic cancer	0.00028	0.000785	CcSEcCtD
Glycine—Hypotension—Ifosfamide—hematologic cancer	0.00028	0.000785	CcSEcCtD
Glycine—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000279	0.000782	CcSEcCtD
Glycine—Urticaria—Bleomycin—hematologic cancer	0.000278	0.00078	CcSEcCtD
Glycine—Tachycardia—Mitoxantrone—hematologic cancer	0.000277	0.000778	CcSEcCtD
Glycine—Oedema—Gemcitabine—hematologic cancer	0.000277	0.000777	CcSEcCtD
Glycine—Vomiting—Cladribine—hematologic cancer	0.000275	0.000771	CcSEcCtD
Glycine—Dizziness—Vinblastine—hematologic cancer	0.000274	0.000769	CcSEcCtD
Glycine—Convulsion—Cisplatin—hematologic cancer	0.000274	0.000768	CcSEcCtD
Glycine—Urticaria—Vinorelbine—hematologic cancer	0.000274	0.000768	CcSEcCtD
Glycine—Hypotension—Vincristine—hematologic cancer	0.000273	0.000765	CcSEcCtD
Glycine—Pain—Thalidomide—hematologic cancer	0.000272	0.000764	CcSEcCtD
Glycine—Hyponatraemia—Epirubicin—hematologic cancer	0.000271	0.000759	CcSEcCtD
Glycine—Diarrhoea—Melphalan—hematologic cancer	0.00027	0.000757	CcSEcCtD
Glycine—Vision blurred—Prednisolone—hematologic cancer	0.000269	0.000755	CcSEcCtD
Glycine—Nausea—Chlorambucil—hematologic cancer	0.000269	0.000754	CcSEcCtD
Glycine—Hypotension—Irinotecan—hematologic cancer	0.000266	0.000745	CcSEcCtD
Glycine—Hypotension—Mitoxantrone—hematologic cancer	0.000266	0.000745	CcSEcCtD
Glycine—Visual impairment—Betamethasone—hematologic cancer	0.000264	0.00074	CcSEcCtD
Glycine—Visual impairment—Dexamethasone—hematologic cancer	0.000264	0.00074	CcSEcCtD
Glycine—Vomiting—Vinblastine—hematologic cancer	0.000264	0.00074	CcSEcCtD
Glycine—Nausea—Nilotinib—hematologic cancer	0.000263	0.000737	CcSEcCtD
Glycine—Diarrhoea—Lenalidomide—hematologic cancer	0.000262	0.000736	CcSEcCtD
Glycine—Urticaria—Thiotepa—hematologic cancer	0.000261	0.000733	CcSEcCtD
Glycine—Pain—Carmustine—hematologic cancer	0.000261	0.000733	CcSEcCtD
Glycine—Nausea—Imatinib—hematologic cancer	0.000261	0.000733	CcSEcCtD
Glycine—Vertigo—Etoposide—hematologic cancer	0.00026	0.00073	CcSEcCtD
Glycine—Hypersensitivity—Bortezomib—hematologic cancer	0.00026	0.000729	CcSEcCtD
Glycine—Pain—Alitretinoin—hematologic cancer	0.000259	0.000726	CcSEcCtD
Glycine—Diarrhoea—Hydroxyurea—hematologic cancer	0.000259	0.000726	CcSEcCtD
Glycine—Hypotension—Gemcitabine—hematologic cancer	0.000259	0.000726	CcSEcCtD
Glycine—Oedema—Cisplatin—hematologic cancer	0.000258	0.000724	CcSEcCtD
Glycine—Hypersensitivity—Bleomycin—hematologic cancer	0.000258	0.000724	CcSEcCtD
Glycine—Nausea—Cladribine—hematologic cancer	0.000257	0.00072	CcSEcCtD
Glycine—Vertigo—Prednisolone—hematologic cancer	0.000257	0.00072	CcSEcCtD
Glycine—Pain—Ifosfamide—hematologic cancer	0.000256	0.000718	CcSEcCtD
Glycine—Back pain—Triamcinolone—hematologic cancer	0.000254	0.000713	CcSEcCtD
Glycine—Hypersensitivity—Vinorelbine—hematologic cancer	0.000254	0.000712	CcSEcCtD
Glycine—Dizziness—Lenalidomide—hematologic cancer	0.000254	0.000711	CcSEcCtD
Glycine—Urticaria—Thalidomide—hematologic cancer	0.000253	0.000709	CcSEcCtD
Glycine—Tachycardia—Cisplatin—hematologic cancer	0.000252	0.000706	CcSEcCtD
Glycine—Convulsion—Etoposide—hematologic cancer	0.000251	0.000704	CcSEcCtD
Glycine—Vomiting—Melphalan—hematologic cancer	0.000251	0.000703	CcSEcCtD
Glycine—Dehydration—Epirubicin—hematologic cancer	0.000251	0.000703	CcSEcCtD
Glycine—Hyponatraemia—Doxorubicin—hematologic cancer	0.00025	0.000703	CcSEcCtD
Glycine—Dizziness—Hydroxyurea—hematologic cancer	0.00025	0.000701	CcSEcCtD
Glycine—Pain—Vincristine—hematologic cancer	0.00025	0.0007	CcSEcCtD
Glycine—Convulsion—Prednisolone—hematologic cancer	0.000248	0.000694	CcSEcCtD
Glycine—Nausea—Vinblastine—hematologic cancer	0.000246	0.000691	CcSEcCtD
Glycine—Vomiting—Lenalidomide—hematologic cancer	0.000244	0.000684	CcSEcCtD
Glycine—Pain—Mitoxantrone—hematologic cancer	0.000243	0.000682	CcSEcCtD
Glycine—Pain—Irinotecan—hematologic cancer	0.000243	0.000682	CcSEcCtD
Glycine—Hypersensitivity—Thiotepa—hematologic cancer	0.000242	0.00068	CcSEcCtD
Glycine—Diarrhoea—Bortezomib—hematologic cancer	0.000241	0.000677	CcSEcCtD
Glycine—Hypotension—Cisplatin—hematologic cancer	0.000241	0.000676	CcSEcCtD
Glycine—Urticaria—Alitretinoin—hematologic cancer	0.000241	0.000675	CcSEcCtD
Glycine—Vomiting—Hydroxyurea—hematologic cancer	0.00024	0.000674	CcSEcCtD
Glycine—Urticaria—Ifosfamide—hematologic cancer	0.000238	0.000667	CcSEcCtD
Glycine—Pain—Gemcitabine—hematologic cancer	0.000237	0.000664	CcSEcCtD
Glycine—Vertigo—Triamcinolone—hematologic cancer	0.000236	0.000662	CcSEcCtD
Glycine—Diarrhoea—Vinorelbine—hematologic cancer	0.000236	0.000661	CcSEcCtD
Glycine—Hypersensitivity—Thalidomide—hematologic cancer	0.000235	0.000658	CcSEcCtD
Glycine—Nausea—Melphalan—hematologic cancer	0.000234	0.000657	CcSEcCtD
Glycine—Dizziness—Bortezomib—hematologic cancer	0.000233	0.000655	CcSEcCtD
Glycine—Oedema—Prednisolone—hematologic cancer	0.000233	0.000654	CcSEcCtD
Glycine—Dehydration—Doxorubicin—hematologic cancer	0.000232	0.000651	CcSEcCtD
Glycine—Tachycardia—Etoposide—hematologic cancer	0.000231	0.000647	CcSEcCtD
Glycine—Dizziness—Vinorelbine—hematologic cancer	0.000228	0.000639	CcSEcCtD
Glycine—Nausea—Lenalidomide—hematologic cancer	0.000228	0.000639	CcSEcCtD
Glycine—Convulsion—Triamcinolone—hematologic cancer	0.000228	0.000639	CcSEcCtD
Glycine—Tachycardia—Prednisolone—hematologic cancer	0.000228	0.000638	CcSEcCtD
Glycine—Angina pectoris—Epirubicin—hematologic cancer	0.000227	0.000637	CcSEcCtD
Glycine—Urticaria—Mitoxantrone—hematologic cancer	0.000226	0.000633	CcSEcCtD
Glycine—Hypersensitivity—Carmustine—hematologic cancer	0.000225	0.000632	CcSEcCtD
Glycine—Diarrhoea—Thiotepa—hematologic cancer	0.000225	0.000632	CcSEcCtD
Glycine—Nausea—Hydroxyurea—hematologic cancer	0.000225	0.00063	CcSEcCtD
Glycine—Vomiting—Bortezomib—hematologic cancer	0.000224	0.000629	CcSEcCtD
Glycine—Hypersensitivity—Alitretinoin—hematologic cancer	0.000223	0.000626	CcSEcCtD
Glycine—Vomiting—Bleomycin—hematologic cancer	0.000223	0.000625	CcSEcCtD
Glycine—Hypotension—Etoposide—hematologic cancer	0.000221	0.00062	CcSEcCtD
Glycine—Pain—Cisplatin—hematologic cancer	0.000221	0.000619	CcSEcCtD
Glycine—Hypersensitivity—Ifosfamide—hematologic cancer	0.000221	0.000619	CcSEcCtD
Glycine—Vomiting—Vinorelbine—hematologic cancer	0.000219	0.000615	CcSEcCtD
Glycine—Diarrhoea—Thalidomide—hematologic cancer	0.000218	0.000611	CcSEcCtD
Glycine—Dizziness—Thiotepa—hematologic cancer	0.000218	0.00061	CcSEcCtD
Glycine—Hypersensitivity—Vincristine—hematologic cancer	0.000215	0.000603	CcSEcCtD
Glycine—Oedema—Triamcinolone—hematologic cancer	0.000214	0.000601	CcSEcCtD
Glycine—Vertigo—Betamethasone—hematologic cancer	0.000214	0.000601	CcSEcCtD
Glycine—Vertigo—Dexamethasone—hematologic cancer	0.000214	0.000601	CcSEcCtD
Glycine—Dizziness—Thalidomide—hematologic cancer	0.000211	0.00059	CcSEcCtD
Glycine—Angina pectoris—Doxorubicin—hematologic cancer	0.00021	0.000589	CcSEcCtD
Glycine—Nausea—Bortezomib—hematologic cancer	0.00021	0.000588	CcSEcCtD
Glycine—Hypersensitivity—Irinotecan—hematologic cancer	0.000209	0.000587	CcSEcCtD
Glycine—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000209	0.000587	CcSEcCtD
Glycine—Tachycardia—Triamcinolone—hematologic cancer	0.000209	0.000587	CcSEcCtD
Glycine—Vomiting—Thiotepa—hematologic cancer	0.000209	0.000587	CcSEcCtD
Glycine—Diarrhoea—Carmustine—hematologic cancer	0.000209	0.000587	CcSEcCtD
Glycine—Nausea—Bleomycin—hematologic cancer	0.000208	0.000584	CcSEcCtD
Glycine—Diarrhoea—Alitretinoin—hematologic cancer	0.000207	0.000581	CcSEcCtD
Glycine—Convulsion—Dexamethasone—hematologic cancer	0.000207	0.000579	CcSEcCtD
Glycine—Convulsion—Betamethasone—hematologic cancer	0.000207	0.000579	CcSEcCtD
Glycine—Diarrhoea—Ifosfamide—hematologic cancer	0.000205	0.000574	CcSEcCtD
Glycine—Nausea—Vinorelbine—hematologic cancer	0.000205	0.000574	CcSEcCtD
Glycine—Vomiting—Thalidomide—hematologic cancer	0.000202	0.000568	CcSEcCtD
Glycine—Dizziness—Carmustine—hematologic cancer	0.000202	0.000567	CcSEcCtD
Glycine—Pain—Etoposide—hematologic cancer	0.000202	0.000567	CcSEcCtD
Glycine—Dizziness—Alitretinoin—hematologic cancer	0.0002	0.000562	CcSEcCtD
Glycine—Diarrhoea—Vincristine—hematologic cancer	0.0002	0.00056	CcSEcCtD
Glycine—Pain—Prednisolone—hematologic cancer	0.000199	0.000559	CcSEcCtD
Glycine—Dizziness—Ifosfamide—hematologic cancer	0.000198	0.000555	CcSEcCtD
Glycine—Vision blurred—Prednisone—hematologic cancer	0.000196	0.000549	CcSEcCtD
Glycine—Nausea—Thiotepa—hematologic cancer	0.000196	0.000548	CcSEcCtD
Glycine—Oedema—Dexamethasone—hematologic cancer	0.000195	0.000546	CcSEcCtD
Glycine—Oedema—Betamethasone—hematologic cancer	0.000195	0.000546	CcSEcCtD
Glycine—Diarrhoea—Irinotecan—hematologic cancer	0.000194	0.000545	CcSEcCtD
Glycine—Diarrhoea—Mitoxantrone—hematologic cancer	0.000194	0.000545	CcSEcCtD
Glycine—Vomiting—Carmustine—hematologic cancer	0.000194	0.000545	CcSEcCtD
Glycine—Dizziness—Vincristine—hematologic cancer	0.000193	0.000541	CcSEcCtD
Glycine—Vomiting—Alitretinoin—hematologic cancer	0.000193	0.00054	CcSEcCtD
Glycine—Visual impairment—Methotrexate—hematologic cancer	0.000192	0.000539	CcSEcCtD
Glycine—Vomiting—Ifosfamide—hematologic cancer	0.00019	0.000534	CcSEcCtD
Glycine—Hypersensitivity—Cisplatin—hematologic cancer	0.00019	0.000533	CcSEcCtD
Glycine—Tachycardia—Dexamethasone—hematologic cancer	0.00019	0.000533	CcSEcCtD
Glycine—Tachycardia—Betamethasone—hematologic cancer	0.00019	0.000533	CcSEcCtD
Glycine—Diarrhoea—Gemcitabine—hematologic cancer	0.000189	0.000531	CcSEcCtD
Glycine—Nausea—Thalidomide—hematologic cancer	0.000189	0.00053	CcSEcCtD
Glycine—Dizziness—Irinotecan—hematologic cancer	0.000188	0.000527	CcSEcCtD
Glycine—Urticaria—Etoposide—hematologic cancer	0.000188	0.000527	CcSEcCtD
Glycine—Rhinitis—Epirubicin—hematologic cancer	0.000187	0.000525	CcSEcCtD
Glycine—Vertigo—Prednisone—hematologic cancer	0.000187	0.000523	CcSEcCtD
Glycine—Vomiting—Vincristine—hematologic cancer	0.000186	0.00052	CcSEcCtD
Glycine—Urticaria—Prednisolone—hematologic cancer	0.000185	0.00052	CcSEcCtD
Glycine—ALAS1—Budesonide—Dexamethasone—hematologic cancer	0.000184	0.02	CbGdCrCtD
Glycine—ALAS1—Budesonide—Betamethasone—hematologic cancer	0.000184	0.02	CbGdCrCtD
Glycine—Pain—Triamcinolone—hematologic cancer	0.000183	0.000514	CcSEcCtD
Glycine—Hypotension—Dexamethasone—hematologic cancer	0.000182	0.00051	CcSEcCtD
Glycine—Hypotension—Betamethasone—hematologic cancer	0.000182	0.00051	CcSEcCtD
Glycine—Nausea—Carmustine—hematologic cancer	0.000182	0.000509	CcSEcCtD
Glycine—Vomiting—Mitoxantrone—hematologic cancer	0.000181	0.000507	CcSEcCtD
Glycine—Vomiting—Irinotecan—hematologic cancer	0.000181	0.000507	CcSEcCtD
Glycine—Nausea—Alitretinoin—hematologic cancer	0.00018	0.000505	CcSEcCtD
Glycine—Convulsion—Prednisone—hematologic cancer	0.00018	0.000505	CcSEcCtD
Glycine—ALAS1—Budesonide—Triamcinolone—hematologic cancer	0.00018	0.0196	CbGdCrCtD
Glycine—Visual impairment—Epirubicin—hematologic cancer	0.00018	0.000504	CcSEcCtD
Glycine—Chills—Methotrexate—hematologic cancer	0.000179	0.000502	CcSEcCtD
Glycine—Nausea—Ifosfamide—hematologic cancer	0.000178	0.000499	CcSEcCtD
Glycine—Diarrhoea—Cisplatin—hematologic cancer	0.000177	0.000495	CcSEcCtD
Glycine—Vomiting—Gemcitabine—hematologic cancer	0.000176	0.000494	CcSEcCtD
Glycine—Hypersensitivity—Etoposide—hematologic cancer	0.000174	0.000489	CcSEcCtD
Glycine—Nausea—Vincristine—hematologic cancer	0.000173	0.000486	CcSEcCtD
Glycine—Rhinitis—Doxorubicin—hematologic cancer	0.000173	0.000485	CcSEcCtD
Glycine—Hypersensitivity—Prednisolone—hematologic cancer	0.000172	0.000482	CcSEcCtD
Glycine—ALAS1—Budesonide—Prednisone—hematologic cancer	0.000171	0.0186	CbGdCrCtD
Glycine—Urticaria—Triamcinolone—hematologic cancer	0.00017	0.000478	CcSEcCtD
Glycine—Oedema—Prednisone—hematologic cancer	0.000169	0.000475	CcSEcCtD
Glycine—Nausea—Mitoxantrone—hematologic cancer	0.000169	0.000474	CcSEcCtD
Glycine—Nausea—Irinotecan—hematologic cancer	0.000169	0.000474	CcSEcCtD
Glycine—Back pain—Methotrexate—hematologic cancer	0.000168	0.000471	CcSEcCtD
Glycine—Chills—Epirubicin—hematologic cancer	0.000167	0.000469	CcSEcCtD
Glycine—ALAS1—Budesonide—Prednisolone—hematologic cancer	0.000167	0.0181	CbGdCrCtD
Glycine—Pain—Dexamethasone—hematologic cancer	0.000166	0.000467	CcSEcCtD
Glycine—Pain—Betamethasone—hematologic cancer	0.000166	0.000467	CcSEcCtD
Glycine—Visual impairment—Doxorubicin—hematologic cancer	0.000166	0.000467	CcSEcCtD
Glycine—Tachycardia—Prednisone—hematologic cancer	0.000165	0.000464	CcSEcCtD
Glycine—Nausea—Gemcitabine—hematologic cancer	0.000164	0.000461	CcSEcCtD
Glycine—Vomiting—Cisplatin—hematologic cancer	0.000164	0.00046	CcSEcCtD
Glycine—Vision blurred—Methotrexate—hematologic cancer	0.000164	0.000459	CcSEcCtD
Glycine—Diarrhoea—Etoposide—hematologic cancer	0.000162	0.000454	CcSEcCtD
Glycine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000158	0.000443	CcSEcCtD
Glycine—Back pain—Epirubicin—hematologic cancer	0.000157	0.000441	CcSEcCtD
Glycine—Dizziness—Etoposide—hematologic cancer	0.000156	0.000438	CcSEcCtD
Glycine—Vertigo—Methotrexate—hematologic cancer	0.000156	0.000437	CcSEcCtD
Glycine—Chills—Doxorubicin—hematologic cancer	0.000155	0.000434	CcSEcCtD
Glycine—Urticaria—Betamethasone—hematologic cancer	0.000155	0.000434	CcSEcCtD
Glycine—Urticaria—Dexamethasone—hematologic cancer	0.000155	0.000434	CcSEcCtD
Glycine—Dizziness—Prednisolone—hematologic cancer	0.000154	0.000432	CcSEcCtD
Glycine—Nausea—Cisplatin—hematologic cancer	0.000153	0.00043	CcSEcCtD
Glycine—Vision blurred—Epirubicin—hematologic cancer	0.000153	0.000429	CcSEcCtD
Glycine—Convulsion—Methotrexate—hematologic cancer	0.00015	0.000422	CcSEcCtD
Glycine—Vomiting—Etoposide—hematologic cancer	0.00015	0.000422	CcSEcCtD
Glycine—Vertigo—Epirubicin—hematologic cancer	0.000146	0.000409	CcSEcCtD
Glycine—Back pain—Doxorubicin—hematologic cancer	0.000145	0.000408	CcSEcCtD
Glycine—Dizziness—Triamcinolone—hematologic cancer	0.000142	0.000398	CcSEcCtD
Glycine—Vision blurred—Doxorubicin—hematologic cancer	0.000142	0.000397	CcSEcCtD
Glycine—Convulsion—Epirubicin—hematologic cancer	0.000141	0.000395	CcSEcCtD
Glycine—Nausea—Etoposide—hematologic cancer	0.00014	0.000394	CcSEcCtD
Glycine—Nausea—Prednisolone—hematologic cancer	0.000139	0.000388	CcSEcCtD
Glycine—Vomiting—Triamcinolone—hematologic cancer	0.000136	0.000382	CcSEcCtD
Glycine—Vertigo—Doxorubicin—hematologic cancer	0.000135	0.000379	CcSEcCtD
Glycine—Urticaria—Prednisone—hematologic cancer	0.000135	0.000378	CcSEcCtD
Glycine—Diarrhoea—Dexamethasone—hematologic cancer	0.000133	0.000373	CcSEcCtD
Glycine—Diarrhoea—Betamethasone—hematologic cancer	0.000133	0.000373	CcSEcCtD
Glycine—Oedema—Epirubicin—hematologic cancer	0.000133	0.000372	CcSEcCtD
Glycine—Hypotension—Methotrexate—hematologic cancer	0.000132	0.000371	CcSEcCtD
Glycine—Convulsion—Doxorubicin—hematologic cancer	0.00013	0.000365	CcSEcCtD
Glycine—Tachycardia—Epirubicin—hematologic cancer	0.000129	0.000363	CcSEcCtD
Glycine—Dizziness—Betamethasone—hematologic cancer	0.000129	0.000361	CcSEcCtD
Glycine—Dizziness—Dexamethasone—hematologic cancer	0.000129	0.000361	CcSEcCtD
Glycine—Nausea—Triamcinolone—hematologic cancer	0.000127	0.000357	CcSEcCtD
Glycine—Hypersensitivity—Prednisone—hematologic cancer	0.000125	0.00035	CcSEcCtD
Glycine—Hypotension—Epirubicin—hematologic cancer	0.000124	0.000347	CcSEcCtD
Glycine—Vomiting—Betamethasone—hematologic cancer	0.000124	0.000347	CcSEcCtD
Glycine—Vomiting—Dexamethasone—hematologic cancer	0.000124	0.000347	CcSEcCtD
Glycine—Oedema—Doxorubicin—hematologic cancer	0.000123	0.000344	CcSEcCtD
Glycine—Pain—Methotrexate—hematologic cancer	0.000121	0.00034	CcSEcCtD
Glycine—Tachycardia—Doxorubicin—hematologic cancer	0.00012	0.000336	CcSEcCtD
Glycine—Diarrhoea—Prednisone—hematologic cancer	0.000116	0.000325	CcSEcCtD
Glycine—Nausea—Betamethasone—hematologic cancer	0.000116	0.000324	CcSEcCtD
Glycine—Nausea—Dexamethasone—hematologic cancer	0.000116	0.000324	CcSEcCtD
Glycine—Hypotension—Doxorubicin—hematologic cancer	0.000115	0.000321	CcSEcCtD
Glycine—Pain—Epirubicin—hematologic cancer	0.000113	0.000318	CcSEcCtD
Glycine—ALAS1—Betamethasone—Dexamethasone—hematologic cancer	0.000113	0.0122	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Betamethasone—hematologic cancer	0.000113	0.0122	CbGdCrCtD
Glycine—Urticaria—Methotrexate—hematologic cancer	0.000113	0.000316	CcSEcCtD
Glycine—Dizziness—Prednisone—hematologic cancer	0.000112	0.000314	CcSEcCtD
Glycine—ALAS1—Dexamethasone—Triamcinolone—hematologic cancer	0.00011	0.012	CbGdCrCtD
Glycine—ALAS1—Betamethasone—Triamcinolone—hematologic cancer	0.00011	0.012	CbGdCrCtD
Glycine—Vomiting—Prednisone—hematologic cancer	0.000108	0.000302	CcSEcCtD
Glycine—Urticaria—Epirubicin—hematologic cancer	0.000105	0.000295	CcSEcCtD
Glycine—Pain—Doxorubicin—hematologic cancer	0.000105	0.000294	CcSEcCtD
Glycine—ALAS1—Betamethasone—Prednisone—hematologic cancer	0.000104	0.0113	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Prednisone—hematologic cancer	0.000104	0.0113	CbGdCrCtD
Glycine—Hypersensitivity—Methotrexate—hematologic cancer	0.000104	0.000293	CcSEcCtD
Glycine—ALAS1—Betamethasone—Prednisolone—hematologic cancer	0.000102	0.0111	CbGdCrCtD
Glycine—ALAS1—Dexamethasone—Prednisolone—hematologic cancer	0.000102	0.0111	CbGdCrCtD
Glycine—Nausea—Prednisone—hematologic cancer	0.000101	0.000282	CcSEcCtD
Glycine—Hypersensitivity—Epirubicin—hematologic cancer	9.76e-05	0.000274	CcSEcCtD
Glycine—Urticaria—Doxorubicin—hematologic cancer	9.74e-05	0.000273	CcSEcCtD
Glycine—Diarrhoea—Methotrexate—hematologic cancer	9.69e-05	0.000272	CcSEcCtD
Glycine—Dizziness—Methotrexate—hematologic cancer	9.36e-05	0.000263	CcSEcCtD
Glycine—Diarrhoea—Epirubicin—hematologic cancer	9.07e-05	0.000254	CcSEcCtD
Glycine—Hypersensitivity—Doxorubicin—hematologic cancer	9.03e-05	0.000253	CcSEcCtD
Glycine—Vomiting—Methotrexate—hematologic cancer	9e-05	0.000253	CcSEcCtD
Glycine—Dizziness—Epirubicin—hematologic cancer	8.76e-05	0.000246	CcSEcCtD
Glycine—Vomiting—Epirubicin—hematologic cancer	8.43e-05	0.000236	CcSEcCtD
Glycine—Nausea—Methotrexate—hematologic cancer	8.41e-05	0.000236	CcSEcCtD
Glycine—Diarrhoea—Doxorubicin—hematologic cancer	8.39e-05	0.000235	CcSEcCtD
Glycine—Dizziness—Doxorubicin—hematologic cancer	8.11e-05	0.000227	CcSEcCtD
Glycine—Nausea—Epirubicin—hematologic cancer	7.87e-05	0.000221	CcSEcCtD
Glycine—Vomiting—Doxorubicin—hematologic cancer	7.8e-05	0.000219	CcSEcCtD
Glycine—Nausea—Doxorubicin—hematologic cancer	7.28e-05	0.000204	CcSEcCtD
Glycine—SHMT1—Disease—KITLG—hematologic cancer	3.05e-05	8.29e-05	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.01e-05	8.16e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—MTHFR—hematologic cancer	3e-05	8.13e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CB—hematologic cancer	2.99e-05	8.12e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CD44—hematologic cancer	2.99e-05	8.11e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—NQO1—hematologic cancer	2.99e-05	8.11e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—STAT5A—hematologic cancer	2.98e-05	8.1e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL2RA—hematologic cancer	2.97e-05	8.07e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ABCB1—hematologic cancer	2.97e-05	8.06e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.96e-05	8.04e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CG—hematologic cancer	2.96e-05	8.04e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CG—hematologic cancer	2.96e-05	8.04e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CG—hematologic cancer	2.96e-05	8.04e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CG—hematologic cancer	2.96e-05	8.04e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN2B—hematologic cancer	2.96e-05	8.03e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL2—hematologic cancer	2.95e-05	8e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TERT—hematologic cancer	2.94e-05	7.98e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.92e-05	7.93e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—MTHFR—hematologic cancer	2.9e-05	7.88e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYCS—hematologic cancer	2.9e-05	7.87e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—NCOR1—hematologic cancer	2.88e-05	7.82e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—HSP90AA1—hematologic cancer	2.88e-05	7.82e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GSTM1—hematologic cancer	2.88e-05	7.82e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PDGFB—hematologic cancer	2.87e-05	7.78e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CD86—hematologic cancer	2.86e-05	7.77e-05	CbGpPWpGaD
Glycine—GARS—Gene Expression—MAPK3—hematologic cancer	2.84e-05	7.71e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CYCS—hematologic cancer	2.83e-05	7.67e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CG—hematologic cancer	2.82e-05	7.67e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—HES1—hematologic cancer	2.82e-05	7.66e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—HSP90AA1—hematologic cancer	2.81e-05	7.62e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NCOR1—hematologic cancer	2.81e-05	7.62e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TSC2—hematologic cancer	2.8e-05	7.61e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—FGF1—hematologic cancer	2.77e-05	7.53e-05	CbGpPWpGaD
Glycine—GARS—Gene Expression—MYC—hematologic cancer	2.76e-05	7.5e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CREBBP—hematologic cancer	2.74e-05	7.45e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—CREBBP—hematologic cancer	2.74e-05	7.45e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CREBBP—hematologic cancer	2.74e-05	7.45e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CREBBP—hematologic cancer	2.74e-05	7.45e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—FOXO1—hematologic cancer	2.73e-05	7.42e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PDGFRB—hematologic cancer	2.73e-05	7.41e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FGFR3—hematologic cancer	2.7e-05	7.32e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PDGFRA—hematologic cancer	2.69e-05	7.29e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—JAK1—hematologic cancer	2.68e-05	7.27e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PRKCG—hematologic cancer	2.68e-05	7.27e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAPK14—hematologic cancer	2.67e-05	7.25e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ESR1—hematologic cancer	2.62e-05	7.11e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—CREBBP—hematologic cancer	2.62e-05	7.11e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CD—hematologic cancer	2.6e-05	7.06e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CD—hematologic cancer	2.6e-05	7.06e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CD—hematologic cancer	2.6e-05	7.06e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CD—hematologic cancer	2.6e-05	7.06e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FN1—hematologic cancer	2.59e-05	7.02e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTEN—hematologic cancer	2.59e-05	7.02e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ALB—hematologic cancer	2.57e-05	6.97e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—ALB—hematologic cancer	2.57e-05	6.97e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ALB—hematologic cancer	2.57e-05	6.97e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ALB—hematologic cancer	2.57e-05	6.97e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GSTP1—hematologic cancer	2.56e-05	6.94e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.56e-05	6.94e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—BAD—hematologic cancer	2.56e-05	6.94e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NFKBIA—hematologic cancer	2.56e-05	6.94e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—MTHFR—hematologic cancer	2.55e-05	6.91e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NOTCH1—hematologic cancer	2.53e-05	6.87e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CG—hematologic cancer	2.52e-05	6.83e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GSTP1—hematologic cancer	2.49e-05	6.76e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CD—hematologic cancer	2.48e-05	6.74e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CD80—hematologic cancer	2.48e-05	6.73e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MTHFR—hematologic cancer	2.48e-05	6.73e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CG—hematologic cancer	2.48e-05	6.72e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KIT—hematologic cancer	2.48e-05	6.72e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—NRAS—hematologic cancer	2.48e-05	6.72e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—TERT—hematologic cancer	2.47e-05	6.71e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—HLA-A—hematologic cancer	2.47e-05	6.71e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—EP300—hematologic cancer	2.47e-05	6.7e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3R1—hematologic cancer	2.46e-05	6.67e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3R1—hematologic cancer	2.46e-05	6.67e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3R1—hematologic cancer	2.46e-05	6.67e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3R1—hematologic cancer	2.46e-05	6.67e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—ALB—hematologic cancer	2.45e-05	6.65e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CG—hematologic cancer	2.44e-05	6.62e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PTPN11—hematologic cancer	2.43e-05	6.6e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ABCB1—hematologic cancer	2.42e-05	6.57e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PDGFB—hematologic cancer	2.41e-05	6.55e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—MAPK3—hematologic cancer	2.37e-05	6.44e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—TSC2—hematologic cancer	2.36e-05	6.4e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ABCB1—hematologic cancer	2.36e-05	6.4e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CREB1—hematologic cancer	2.36e-05	6.4e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GSTM1—hematologic cancer	2.35e-05	6.38e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—NCOR1—hematologic cancer	2.35e-05	6.38e-05	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—HRAS—hematologic cancer	2.35e-05	6.38e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3R1—hematologic cancer	2.34e-05	6.36e-05	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.34e-05	6.35e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—CREBBP—hematologic cancer	2.33e-05	6.33e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—BRAF—hematologic cancer	2.33e-05	6.32e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCL2—hematologic cancer	2.31e-05	6.26e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6R—hematologic cancer	2.3e-05	6.24e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CREBBP—hematologic cancer	2.29e-05	6.23e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—NCOR1—hematologic cancer	2.29e-05	6.22e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GSTM1—hematologic cancer	2.29e-05	6.22e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—FGFR3—hematologic cancer	2.27e-05	6.16e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CB—hematologic cancer	2.27e-05	6.16e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CB—hematologic cancer	2.27e-05	6.16e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CB—hematologic cancer	2.27e-05	6.16e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CB—hematologic cancer	2.27e-05	6.16e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CREBBP—hematologic cancer	2.26e-05	6.14e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CD—hematologic cancer	2.21e-05	6.01e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAP2K1—hematologic cancer	2.19e-05	5.95e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—ALB—hematologic cancer	2.18e-05	5.93e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CD—hematologic cancer	2.18e-05	5.91e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CB—hematologic cancer	2.16e-05	5.87e-05	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—PIK3CA—hematologic cancer	2.16e-05	5.85e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—BAD—hematologic cancer	2.15e-05	5.84e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CD—hematologic cancer	2.14e-05	5.82e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CG—hematologic cancer	2.14e-05	5.81e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—KRAS—hematologic cancer	2.13e-05	5.78e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NOTCH1—hematologic cancer	2.13e-05	5.78e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ALB—hematologic cancer	2.12e-05	5.74e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3R1—hematologic cancer	2.09e-05	5.67e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CD80—hematologic cancer	2.09e-05	5.67e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FGF2—hematologic cancer	2.08e-05	5.66e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—KIT—hematologic cancer	2.08e-05	5.66e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—MTHFR—hematologic cancer	2.08e-05	5.64e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3R1—hematologic cancer	2.05e-05	5.58e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTPN11—hematologic cancer	2.05e-05	5.56e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—MTHFR—hematologic cancer	2.02e-05	5.49e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3R1—hematologic cancer	2.02e-05	5.49e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—JAK2—hematologic cancer	2e-05	5.42e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CREBBP—hematologic cancer	1.98e-05	5.39e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CREB1—hematologic cancer	1.98e-05	5.38e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTEN—hematologic cancer	1.96e-05	5.32e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTEN—hematologic cancer	1.96e-05	5.32e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTEN—hematologic cancer	1.96e-05	5.32e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PTEN—hematologic cancer	1.96e-05	5.32e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—BRAF—hematologic cancer	1.96e-05	5.32e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PIK3CA—hematologic cancer	1.96e-05	5.31e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.95e-05	5.3e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MDM2—hematologic cancer	1.95e-05	5.29e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6R—hematologic cancer	1.93e-05	5.25e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CREBBP—hematologic cancer	1.93e-05	5.24e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CB—hematologic cancer	1.93e-05	5.24e-05	CbGpPWpGaD
Glycine—GARS—Gene Expression—AKT1—hematologic cancer	1.92e-05	5.2e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MTOR—hematologic cancer	1.9e-05	5.15e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CB—hematologic cancer	1.9e-05	5.15e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CD—hematologic cancer	1.88e-05	5.11e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTEN—hematologic cancer	1.87e-05	5.08e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—EP300—hematologic cancer	1.87e-05	5.07e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—EP300—hematologic cancer	1.87e-05	5.07e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—EP300—hematologic cancer	1.87e-05	5.07e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—EP300—hematologic cancer	1.87e-05	5.07e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CB—hematologic cancer	1.87e-05	5.07e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ALB—hematologic cancer	1.86e-05	5.04e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MAP2K1—hematologic cancer	1.84e-05	5e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CD—hematologic cancer	1.83e-05	4.97e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ALB—hematologic cancer	1.83e-05	4.96e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CA—hematologic cancer	1.82e-05	4.95e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—HRAS—hematologic cancer	1.81e-05	4.92e-05	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—HRAS—hematologic cancer	1.79e-05	4.87e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—EP300—hematologic cancer	1.78e-05	4.84e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CDKN1B—hematologic cancer	1.78e-05	4.83e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3R1—hematologic cancer	1.78e-05	4.82e-05	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—AKT1—hematologic cancer	1.76e-05	4.78e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—FGF2—hematologic cancer	1.75e-05	4.76e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CG—hematologic cancer	1.74e-05	4.74e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CASP3—hematologic cancer	1.74e-05	4.74e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL2—hematologic cancer	1.74e-05	4.73e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL6—hematologic cancer	1.73e-05	4.7e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3R1—hematologic cancer	1.73e-05	4.69e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CG—hematologic cancer	1.7e-05	4.62e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCND1—hematologic cancer	1.7e-05	4.61e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—JUN—hematologic cancer	1.69e-05	4.6e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—JAK2—hematologic cancer	1.68e-05	4.56e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTEN—hematologic cancer	1.67e-05	4.52e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CDKN1A—hematologic cancer	1.64e-05	4.46e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MDM2—hematologic cancer	1.64e-05	4.45e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CB—hematologic cancer	1.64e-05	4.45e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PTEN—hematologic cancer	1.64e-05	4.45e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CREBBP—hematologic cancer	1.62e-05	4.39e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTEN—hematologic cancer	1.61e-05	4.38e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAPK8—hematologic cancer	1.6e-05	4.35e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—AKT1—hematologic cancer	1.6e-05	4.34e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CB—hematologic cancer	1.6e-05	4.33e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MTOR—hematologic cancer	1.6e-05	4.33e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CD4—hematologic cancer	1.59e-05	4.33e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—EP300—hematologic cancer	1.59e-05	4.31e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CREBBP—hematologic cancer	1.58e-05	4.28e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EP300—hematologic cancer	1.56e-05	4.24e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—EP300—hematologic cancer	1.54e-05	4.18e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CD—hematologic cancer	1.53e-05	4.16e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SRC—hematologic cancer	1.52e-05	4.13e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ALB—hematologic cancer	1.51e-05	4.11e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN1B—hematologic cancer	1.5e-05	4.07e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CD—hematologic cancer	1.49e-05	4.06e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—AKT1—hematologic cancer	1.49e-05	4.05e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—VEGFA—hematologic cancer	1.48e-05	4.02e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ALB—hematologic cancer	1.48e-05	4.01e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—STAT3—hematologic cancer	1.47e-05	3.98e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NRAS—hematologic cancer	1.46e-05	3.97e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3R1—hematologic cancer	1.45e-05	3.93e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTEN—hematologic cancer	1.42e-05	3.85e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3R1—hematologic cancer	1.41e-05	3.83e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAPK3—hematologic cancer	1.4e-05	3.8e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CA—hematologic cancer	1.38e-05	3.75e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CA—hematologic cancer	1.38e-05	3.75e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CA—hematologic cancer	1.38e-05	3.75e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CA—hematologic cancer	1.38e-05	3.75e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN1A—hematologic cancer	1.38e-05	3.75e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTEN—hematologic cancer	1.38e-05	3.74e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MYC—hematologic cancer	1.36e-05	3.7e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TGFB1—hematologic cancer	1.36e-05	3.69e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—EP300—hematologic cancer	1.35e-05	3.67e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CB—hematologic cancer	1.34e-05	3.63e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CA—hematologic cancer	1.32e-05	3.58e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—EP300—hematologic cancer	1.32e-05	3.57e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CB—hematologic cancer	1.3e-05	3.54e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—SRC—hematologic cancer	1.28e-05	3.47e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KRAS—hematologic cancer	1.26e-05	3.42e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—STAT3—hematologic cancer	1.23e-05	3.35e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NRAS—hematologic cancer	1.23e-05	3.34e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MAPK3—hematologic cancer	1.18e-05	3.2e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CA—hematologic cancer	1.18e-05	3.19e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CA—hematologic cancer	1.16e-05	3.14e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTEN—hematologic cancer	1.16e-05	3.14e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MYC—hematologic cancer	1.15e-05	3.11e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—TGFB1—hematologic cancer	1.14e-05	3.1e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CA—hematologic cancer	1.14e-05	3.09e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—AKT1—hematologic cancer	1.13e-05	3.07e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—AKT1—hematologic cancer	1.13e-05	3.07e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—AKT1—hematologic cancer	1.13e-05	3.07e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—AKT1—hematologic cancer	1.13e-05	3.07e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PTEN—hematologic cancer	1.13e-05	3.06e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TP53—hematologic cancer	1.12e-05	3.04e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—EP300—hematologic cancer	1.1e-05	2.99e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—AKT1—hematologic cancer	1.08e-05	2.93e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—EP300—hematologic cancer	1.07e-05	2.91e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HRAS—hematologic cancer	1.07e-05	2.9e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—KRAS—hematologic cancer	1.06e-05	2.88e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6—hematologic cancer	1.02e-05	2.78e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CA—hematologic cancer	1e-05	2.71e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CA—hematologic cancer	9.73e-06	2.64e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—AKT1—hematologic cancer	9.6e-06	2.61e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKT1—hematologic cancer	9.44e-06	2.56e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AKT1—hematologic cancer	9.3e-06	2.53e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—HRAS—hematologic cancer	9e-06	2.44e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6—hematologic cancer	8.62e-06	2.34e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AKT1—hematologic cancer	8.17e-06	2.22e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CA—hematologic cancer	8.15e-06	2.21e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT1—hematologic cancer	7.95e-06	2.16e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CA—hematologic cancer	7.94e-06	2.16e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AKT1—hematologic cancer	6.66e-06	1.81e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—AKT1—hematologic cancer	6.49e-06	1.76e-05	CbGpPWpGaD
